ProShares Short MidCap400 (MYY)
The ProShares Short MidCap400 (NASDAQ: MYY) is an exchange-traded fund that seeks to deliver the opposite of the daily return of the S&P MidCap 400 index — a way to bet against mid-cap US stocks without using margin or short-selling mechanics directly.
The S&P MidCap 400 is composed of roughly four hundred US companies with market capitalizations between roughly $2 billion and $10 billion — the middle tier between large-cap giants and micro-cap penny stocks. Mid-cap firms are often in a sweet spot: large enough to have established operations and competitive positions, small enough that their growth rates can still move sharply on earnings surprises or sector momentum. They are also the least researched corner of the equity market, held by fewer institutional investors than mega-caps and more volatile than the broad market.
MYY allows an investor to gain exposure to a decline in this mid-cap universe without the complexity of borrowing shares and short-selling them in a traditional margin account. Instead, the fund holds a mix of inverse instruments — principally short futures contracts on the MidCap 400 index, along with options and other derivatives — that move downward when the index rises. The effect, under ideal conditions, is a fund that loses 1% on a day when the MidCap 400 gains 1%, and gains 1% when the index falls 1%.
The critical qualifier is “under ideal conditions”. MYY resets daily, meaning that the fund’s leverage and positioning are recalculated at each market close. This daily reset mechanism is essential for understanding how inverse ETFs actually behave over longer time periods. If the MidCap 400 gains 10% in a straight line, MYY should lose roughly 10%. But if the index rises and falls — gyrating 5% up, then 5% down, then 5% up again — the daily resets cause MYY to underperform a simple -10% loss. The fund makes small losses on up days and small gains on down days, but those gains compound at a slower pace than a single -10% move would. This is volatility decay, and it is the defining risk of inverse and leveraged ETFs in choppy markets.
For this reason, MYY is best understood as a tactical hedge or a short-term trading instrument, not a long-term holding. An investor who expects a sharp, directional move downward in mid-cap stocks might use MYY as a way to express that view without borrowing stock in a margin account. Someone holding a concentrated portfolio of mid-cap equities might use a small MYY position to reduce downside risk during periods of elevated uncertainty. But an investor who holds MYY for months or years, expecting a prolonged mid-cap bear market, will likely be disappointed — not because the thesis is wrong, but because volatility decay will erode the fund’s effectiveness as volatility widens.
The fund’s structure also carries tracking error even on days when the index moves in a straight line. The cost of holding short futures and options, the slippage from rebalancing multiple times per day, and the bid-ask spreads on the underlying derivatives all create a drag between what the index does and what MYY delivers. These costs, expressed as the fund’s expense ratio, are material and in line with other inverse ETFs.
MYY is denominated and traded in US dollars on the NASDAQ, so it also carries currency risk only to the extent that the holdings (if any equity positions are held) or the index composition includes non-US firms or revenues. The MidCap 400, however, is a US-only index, so currency is a minor factor.
The fund is best suited to traders and hedgers who understand its reset mechanics and intend to use it over days or weeks, not months or years. For someone seeking a longer-duration short bias in mid-cap stocks, short selling individual stocks, buying protective puts on the broader market, or simply holding cash and waiting to deploy it when prices fall would all be more cost-effective strategies than owning an inverse ETF outright. Like any inverse product, MYY is a tool — powerful if used correctly, expensive and misleading if held without a clear tactical thesis.